Skip to content Skip to footer
Spotlight_Barbara Albientz

Reuters Pharma 2025: Post-Conference Talks Featuring Barbara Albientz

Barbara Albientz, Chief Commercialization Officer, Helvion Pharmaceuticals, joins PharmaShots’ Managing Editor Himanshu Sehgal for a riveting dialogue exchange. Barbara shares her experience from the recently held Reuters Events Pharma 2025, where she joined as an affirmative team member for the debate Reality Check: Is Omnichannel Actually Working?Barbara believes AI will be crucial in segmenting…

Read more

Spotlight Interview_Rahul Mittal

Reuters Pharma USA 2025: Post-Conference Talks featuring Rahul Mittal

Brimming with insightful panel discussions, presentations on disruptive technologies, and illuminating real-world evidence shaping the healthcare landscape now and then, the two-day Reuters event celebrated pharmaceutical innovation and fresh perspectives pouring into the interactive sessions.In the panel discussion at Reuters Pharma USA 2025, Rahul Mittal outlined ways to enhance patient centricity and engagement. Rahul…

Read more

Spotlight Interview_Heba Nowyhed

CXO Talks: Heba Nowyhed from Arcellx in a Candid Conversation with PharmaShots

CAR T-cell therapies hold a promising foothold in addressing unmet healthcare needs. Arcellx, a clinical-stage biotech company, is steadfastly exploring the potential of cell therapy in RRMM and generalized myasthenia gravis patients with its lead asset anito-cel. During presentations at ASH, anito-cel demonstrated no delayed neurotoxicity in both P-1 and pivotal P-II clinical trials for multiple myeloma.…

Read more